ACE2 and chronic obstructive pulmonary disease: One reason that individuals with COPD may be at heightened risk for severe COVID-19 is the increased expression of the angiotensin-converting enzyme 2 (ACE2), the entry receptor for SARS-CoV-2 [6,7].